Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-06-012424
Filing Date
2006-06-01
Accepted
2006-06-01 18:46:34
Documents
2
Period of Report
2006-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3819
2 ex24sherwin.txt EX-24 3048
  Complete submission text file 0001179110-06-012424.txt   8699
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 6502663050
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 06881136